Privi Speciality Chemicals · NSE: PRIVISCL · BSE: 530117

Q3 FY25 results · Oct–Dec 2024

Privi Speciality Chemicals reported revenue from operations of ₹490.87 crore (up 21.6% from Q3 FY24) and net profit of ₹44.47 crore (up 54.6% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY25Q3 FY24YoYQ2 FY25QoQ
Revenue from operations490.87403.81+21.6%532.79−7.9%
Other income2.195.62−61.1%4.47−51.1%
Total income493.06409.43+20.4%537.27−8.2%
Profit before tax60.9239.08+55.9%60.75+0.3%
Net profit for the period44.4728.77+54.6%44.84−0.8%
Attributable to shareholders of the company44.4427.22+63.3%44.66−0.5%
EPS, basic (₹)11.387.37+54.4%11.43−0.4%
Net margin (%)9.17.18.4
Standalone · ₹ crore
ItemQ3 FY25Q3 FY24YoYQ2 FY25QoQ
Revenue from operations498.20401.11+24.2%518.25−3.9%
Other income1.054.93−78.7%3.99−73.7%
Total income499.24406.04+23.0%522.25−4.4%
Profit before tax59.6743.10+38.5%62.61−4.7%
Net profit for the period44.3731.96+38.8%46.59−4.8%
EPS, basic (₹)11.368.18+38.9%11.93−4.8%
Net margin (%)8.98.09.0
Consolidated
Filed with BSE
12 Feb 2025, 16:11 IST
Board meeting
12 Feb 2025
Period
01 Oct 2024 to 31 Dec 2024
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
12 Feb 2025, 16:11 IST
Board meeting
12 Feb 2025
Period
01 Oct 2024 to 31 Dec 2024
Review status
Unaudited
Source
XBRL filing on BSE